Common Stock

9 Months Ended

Sep. 30, 2025

Equity [Abstract]

Common Stock

NOTE 10. Common Stock

Common Stock

2025. During the three months ended September 30, 2025, the Company issued approximately 0.3 million shares of common stock primarily in connection with vesting of stock-based awards. During the nine months ended September 30, 2025, the Company issued approximately 2.4 million shares of common stock primarily in connection with vesting of stock-based awards.

2024. During the three months ended September 30, 2024, the Company issued approximately 0.5 million shares of common stock primarily in connection with exercises and vesting of stock-based awards. During the nine months ended September 30, 2024, the Company issued approximately 3.6 million shares of common stock primarily in connection with exercises and vesting of stock-based awards. Additionally, during the nine months ended September 30, 2024, the

Company issued approximately 2.0 million shares of common stock to settle liabilities related to the exchange of common stock for reduced physician partner compensation percentage in certain ACO REACH entities.